Prevention of liver-related complications with elbasvir/grazoprevir in hepatitis C infected patients who are receiving opioid agonist therapy

被引：0
|
作者：
Corman, S. [1 ]
Jiang, Y. [2 ]
Platt, H. L. [3 ]
Nwankwo, C. [3 ]
机构：
[1] Pharmerit Int, Bethesda, MD USA
[2] Merck Sharp & Dohme Ltd, Hoddesdon, Herts, England
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30913-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-246
引用
下载
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [1] Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy A Randomized Trial
    Dore, Gregory J.
    Altice, Frederick
    Litwin, Alain H.
    Dalgard, Olav
    Gane, Edward J.
    Shibolet, Oren
    Luetkemeyer, Anne
    Nahass, Ronald
    Peng, Cheng-Yuan
    Conway, Brian
    Grebely, Jason
    Howe, Anita Y. M.
    Gendrano, Isaias N.
    Chen, Erluo
    Huang, Hsueh-Cheng
    Dutko, Frank J.
    Nickle, David C.
    Bach-Yen Nguyen
    Wahl, Janice
    Barr, Eliav
    Robertson, Michael N.
    Platt, Heather L.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (09) : 625 - +
  • [2] No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
    Feng, Hwa-Ping
    Guo, Zifang
    Caro, Luzelena
    Marshall, William L.
    Liu, Fang
    Panebianco, Deborah
    Vaddady, Pavan
    Reitmann, Christina
    Jumes, Patricia
    Wolford, Dennis
    Fraser, Iain
    Valesky, Robert
    Martinho, Monika
    Butterton, Joan R.
    Iwamoto, Marian
    Webster, Lynn
    Yeh, Wendy W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (06): : 553 - 561
  • [3] C-EDGE CO-STAR: Efficacy of Grazoprevir and Elbasvir in Persons who Inject Drugs (PWID) Receiving Opioid Agonist Therapy
    Dore, Gregory
    Altice, Frederick
    Litwin, Alain H.
    Dalgard, Olav
    Gane, Edward J.
    Shibolet, Oren
    Luetkemeyer, Anne
    Nahass, Ronald
    Peng, Cheng-Yuan
    Conway, Brian
    Grebely, Jason
    Howe, Anita Y.
    Nguyen, Bach-Yen T.
    Wahl, Janice
    Barr, Eliav
    Robertson, Michael
    Platt, Heather L.
    HEPATOLOGY, 2015, 62 : 227A - 228A
  • [4] EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFFECTION WHO RECEIVE OPIOID AGONIST THERAPY: TREATMENT UTILIZATION AND THE IMPACT OF CONCOMITANT PSYCHIATRIC MEDICATIONS
    Kramer, Jennifer R.
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    GASTROENTEROLOGY, 2019, 156 (06) : S1219 - S1219
  • [5] Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection who receive opioid agonist therapy: Treatment utilization and the impact of concomitant psychiatric medications
    Kramer, Jennifer
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E112 - E112
  • [6] Predictors of liver-related complications in patients with chronic hepatitis C
    Chitturi, S
    George, J
    ANNALS OF MEDICINE, 2000, 32 (09) : 588 - 591
  • [7] Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy
    Macias, Juan
    Tellez, Francisco
    de los Santos, Ignacio
    Morano, Luis E.
    Merino, Dolores
    Granados, Rafael
    Vera-Mendez, Francisco
    Gonzalez-Serna, Alejandro
    Campo-Moneo, Esther
    Garcia-Fraile, Lucio
    Garcia, Federico
    Real, Luis M.
    Pineda, Juan A.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (06) : 878 - 886
  • [8] No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
    Feng, Hwa-Ping
    Guo, Zifang
    Caro, Luzelena
    Marshall, William L.
    Liu, Fang
    Panebianco, Deborah
    Vaddady, Pavan
    Barbour, April
    Reitmann, Christina
    Jumes, Patricia
    Gilmartin, Jocelyn
    Wolford, Dennis
    Valesky, Robert
    Martinho, Monika
    Butterton, Joan R.
    Iwamoto, Marian
    Fraser, Iain
    Webster, Lynn
    Yeh, Wendy W.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (06): : 562 - 572
  • [9] C-EDGE CO-STAR: Risk of reinfection following successful therapy with elbasvir and grazoprevir in persons who inject drugs (PWID) receiving opioid agonist therapy (OAT)
    Dore, G. J.
    Altice, F.
    Litwin, A. H.
    Grebely, J.
    Dalgard, O.
    Gane, E. J.
    Shibolet, O.
    Luetkemeyer, A.
    Nahass, R.
    Peng, C. Y.
    Conway, B.
    Gendrano, I. N.
    Huang, H. C.
    Chen, E.
    Nguyen, B. Y.
    Wahl, J.
    Barr, E.
    Robertson, R.
    Platt, H. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 70 - 71
  • [10] C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR AND GRAZOPREVIR IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT)
    Dore, G.
    Altice, F.
    Litwin, A. H.
    Grebely, J.
    Dalgard, O.
    Gane, E. J.
    Shibolet, O.
    Luetkemeyer, A.
    Nahass, R.
    Peng, C. -Y.
    Conway, B.
    Gendrano, I. N.
    Huang, H. -C.
    Chen, E.
    Nguyen, B. -Y.
    Wahl, J.
    Barr, E.
    Robertson, M.
    Platt, H. L.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S771 - S771
12345